nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ORM1—Propranolol—migraine	0.0837	0.119	CbGbCtD
Gefitinib—ORM1—Amitriptyline—migraine	0.0724	0.103	CbGbCtD
Gefitinib—CYP1A1—Propranolol—migraine	0.0472	0.0672	CbGbCtD
Gefitinib—ABCG2—Verapamil—migraine	0.0351	0.0499	CbGbCtD
Gefitinib—ALB—Amitriptyline—migraine	0.0305	0.0434	CbGbCtD
Gefitinib—CYP3A5—Propranolol—migraine	0.0283	0.0403	CbGbCtD
Gefitinib—CYP2C19—Timolol—migraine	0.0256	0.0365	CbGbCtD
Gefitinib—CYP3A5—Amitriptyline—migraine	0.0245	0.0349	CbGbCtD
Gefitinib—CYP2C19—Propranolol—migraine	0.0228	0.0325	CbGbCtD
Gefitinib—CYP3A5—Valproic Acid—migraine	0.0223	0.0318	CbGbCtD
Gefitinib—ABCB1—Timolol—migraine	0.0207	0.0294	CbGbCtD
Gefitinib—CYP2C19—Amitriptyline—migraine	0.0198	0.0281	CbGbCtD
Gefitinib—CYP2D6—Timolol—migraine	0.0195	0.0277	CbGbCtD
Gefitinib—CYP3A5—Verapamil—migraine	0.0194	0.0277	CbGbCtD
Gefitinib—ABCB1—Propranolol—migraine	0.0184	0.0262	CbGbCtD
Gefitinib—CYP2C19—Valproic Acid—migraine	0.018	0.0256	CbGbCtD
Gefitinib—CYP2D6—Propranolol—migraine	0.0174	0.0247	CbGbCtD
Gefitinib—CYP2C9—Amitriptyline—migraine	0.0164	0.0234	CbGbCtD
Gefitinib—CYP2C19—Topiramate—migraine	0.0162	0.0231	CbGbCtD
Gefitinib—ABCB1—Amitriptyline—migraine	0.0159	0.0227	CbGbCtD
Gefitinib—CYP2C19—Verapamil—migraine	0.0157	0.0223	CbGbCtD
Gefitinib—CYP2D6—Amitriptyline—migraine	0.015	0.0214	CbGbCtD
Gefitinib—CYP2C9—Valproic Acid—migraine	0.015	0.0213	CbGbCtD
Gefitinib—CYP2C9—Verapamil—migraine	0.013	0.0186	CbGbCtD
Gefitinib—ABCB1—Verapamil—migraine	0.0126	0.018	CbGbCtD
Gefitinib—CYP2D6—Verapamil—migraine	0.0119	0.017	CbGbCtD
Gefitinib—CYP3A4—Propranolol—migraine	0.011	0.0157	CbGbCtD
Gefitinib—CYP3A4—Amitriptyline—migraine	0.00955	0.0136	CbGbCtD
Gefitinib—CYP3A4—Valproic Acid—migraine	0.0087	0.0124	CbGbCtD
Gefitinib—CYP3A4—Topiramate—migraine	0.00785	0.0112	CbGbCtD
Gefitinib—CYP3A4—Verapamil—migraine	0.00758	0.0108	CbGbCtD
Gefitinib—ERBB3—peripheral nervous system—migraine	0.00419	0.0644	CbGeAlD
Gefitinib—SBK1—trigeminal ganglion—migraine	0.00297	0.0457	CbGeAlD
Gefitinib—MKNK1—Pindolol—Propranolol—migraine	0.00193	0.524	CbGdCrCtD
Gefitinib—ERBB3—Alprenolol—Propranolol—migraine	0.00175	0.476	CbGdCrCtD
Gefitinib—CSNK1E—trigeminal ganglion—migraine	0.00164	0.0252	CbGeAlD
Gefitinib—IRAK4—trigeminal ganglion—migraine	0.00162	0.0249	CbGeAlD
Gefitinib—MKNK2—trigeminal ganglion—migraine	0.00151	0.0232	CbGeAlD
Gefitinib—MKNK1—trigeminal ganglion—migraine	0.00149	0.0229	CbGeAlD
Gefitinib—Minaprine—HTR2B—migraine	0.00146	0.153	CrCbGaD
Gefitinib—SBK1—head—migraine	0.00145	0.0224	CbGeAlD
Gefitinib—SBK1—cerebellum—migraine	0.0013	0.0199	CbGeAlD
Gefitinib—STK10—trigeminal ganglion—migraine	0.00122	0.0188	CbGeAlD
Gefitinib—Cisapride—HTR3A—migraine	0.00118	0.123	CrCbGaD
Gefitinib—Cisapride—HTR2B—migraine	0.00115	0.121	CrCbGaD
Gefitinib—EPHA6—head—migraine	0.00114	0.0175	CbGeAlD
Gefitinib—MAP2K5—trigeminal ganglion—migraine	0.00109	0.0168	CbGeAlD
Gefitinib—MKNK2—cardiovascular system—migraine	0.00109	0.0167	CbGeAlD
Gefitinib—EPHA6—nervous system—migraine	0.00108	0.0166	CbGeAlD
Gefitinib—MKNK1—cardiovascular system—migraine	0.00107	0.0165	CbGeAlD
Gefitinib—Iloperidone—HTR1D—migraine	0.00107	0.112	CrCbGaD
Gefitinib—SBK1—brain—migraine	0.00105	0.0162	CbGeAlD
Gefitinib—HIPK4—brain—migraine	0.00104	0.016	CbGeAlD
Gefitinib—EPHA6—central nervous system—migraine	0.00104	0.0159	CbGeAlD
Gefitinib—MAP3K19—head—migraine	0.00103	0.0159	CbGeAlD
Gefitinib—MAP3K19—nervous system—migraine	0.000979	0.0151	CbGeAlD
Gefitinib—MAP2K5—brainstem—migraine	0.000968	0.0149	CbGeAlD
Gefitinib—MAP3K19—central nervous system—migraine	0.000942	0.0145	CbGeAlD
Gefitinib—CHEK2—brain—migraine	0.000918	0.0141	CbGeAlD
Gefitinib—STK10—cardiovascular system—migraine	0.000884	0.0136	CbGeAlD
Gefitinib—EPHA6—brain—migraine	0.000823	0.0127	CbGeAlD
Gefitinib—CSNK1E—head—migraine	0.000803	0.0123	CbGeAlD
Gefitinib—IRAK4—head—migraine	0.00079	0.0122	CbGeAlD
Gefitinib—MAP2K5—cardiovascular system—migraine	0.00079	0.0121	CbGeAlD
Gefitinib—ERBB3—head—migraine	0.000775	0.0119	CbGeAlD
Gefitinib—CSNK1E—nervous system—migraine	0.000761	0.0117	CbGeAlD
Gefitinib—IRAK4—nervous system—migraine	0.000749	0.0115	CbGeAlD
Gefitinib—MAP3K19—brain—migraine	0.000748	0.0115	CbGeAlD
Gefitinib—EGFR—cerebellum—migraine	0.000745	0.0115	CbGeAlD
Gefitinib—MKNK2—head—migraine	0.000737	0.0113	CbGeAlD
Gefitinib—ERBB3—nervous system—migraine	0.000734	0.0113	CbGeAlD
Gefitinib—CSNK1E—central nervous system—migraine	0.000733	0.0113	CbGeAlD
Gefitinib—MKNK1—head—migraine	0.000727	0.0112	CbGeAlD
Gefitinib—IRAK4—central nervous system—migraine	0.000721	0.0111	CbGeAlD
Gefitinib—CSNK1E—cerebellum—migraine	0.000716	0.011	CbGeAlD
Gefitinib—Minaprine—HTR2C—migraine	0.000711	0.0746	CrCbGaD
Gefitinib—ERBB3—central nervous system—migraine	0.000707	0.0109	CbGeAlD
Gefitinib—IRAK4—cerebellum—migraine	0.000705	0.0108	CbGeAlD
Gefitinib—MKNK2—nervous system—migraine	0.000698	0.0107	CbGeAlD
Gefitinib—ERBB3—cerebellum—migraine	0.000691	0.0106	CbGeAlD
Gefitinib—MKNK1—nervous system—migraine	0.00069	0.0106	CbGeAlD
Gefitinib—MKNK2—central nervous system—migraine	0.000672	0.0103	CbGeAlD
Gefitinib—MKNK1—central nervous system—migraine	0.000664	0.0102	CbGeAlD
Gefitinib—Iloperidone—HTR7—migraine	0.000657	0.0689	CrCbGaD
Gefitinib—MKNK2—cerebellum—migraine	0.000657	0.0101	CbGeAlD
Gefitinib—IRAK1—cerebellum—migraine	0.000657	0.0101	CbGeAlD
Gefitinib—MKNK1—cerebellum—migraine	0.000649	0.00998	CbGeAlD
Gefitinib—EGFR—brain—migraine	0.000605	0.0093	CbGeAlD
Gefitinib—STK10—head—migraine	0.000599	0.00921	CbGeAlD
Gefitinib—Minaprine—SLC6A4—migraine	0.00059	0.0618	CrCbGaD
Gefitinib—CSNK1E—brain—migraine	0.000582	0.00895	CbGeAlD
Gefitinib—IRAK4—brain—migraine	0.000573	0.00881	CbGeAlD
Gefitinib—STK10—nervous system—migraine	0.000568	0.00873	CbGeAlD
Gefitinib—Cisapride—HTR2C—migraine	0.000562	0.0589	CrCbGaD
Gefitinib—ERBB3—brain—migraine	0.000561	0.00863	CbGeAlD
Gefitinib—STK10—central nervous system—migraine	0.000547	0.00841	CbGeAlD
Gefitinib—MAP2K5—head—migraine	0.000535	0.00823	CbGeAlD
Gefitinib—STK10—cerebellum—migraine	0.000534	0.00822	CbGeAlD
Gefitinib—MKNK2—brain—migraine	0.000534	0.00821	CbGeAlD
Gefitinib—IRAK1—brain—migraine	0.000534	0.00821	CbGeAlD
Gefitinib—ABCG2—trigeminal ganglion—migraine	0.000532	0.00818	CbGeAlD
Gefitinib—MKNK1—brain—migraine	0.000527	0.00811	CbGeAlD
Gefitinib—Iloperidone—HTR2C—migraine	0.000519	0.0544	CrCbGaD
Gefitinib—MAP2K5—nervous system—migraine	0.000507	0.0078	CbGeAlD
Gefitinib—Weight decreased—Valproic Acid—migraine	0.000506	0.0028	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000505	0.0028	CcSEcCtD
Gefitinib—Iloperidone—HTR1A—migraine	0.000504	0.0528	CrCbGaD
Gefitinib—Angioedema—Verapamil—migraine	0.000502	0.00278	CcSEcCtD
Gefitinib—Hepatic failure—Topiramate—migraine	0.000502	0.00278	CcSEcCtD
Gefitinib—Pneumonia—Valproic Acid—migraine	0.000501	0.00278	CcSEcCtD
Gefitinib—Eye pain—Topiramate—migraine	0.0005	0.00277	CcSEcCtD
Gefitinib—Dehydration—Gabapentin—migraine	0.000499	0.00276	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000494	0.00274	CcSEcCtD
Gefitinib—Dry skin—Gabapentin—migraine	0.000492	0.00272	CcSEcCtD
Gefitinib—MAP2K5—central nervous system—migraine	0.000488	0.00751	CbGeAlD
Gefitinib—Stomatitis—Valproic Acid—migraine	0.000486	0.00269	CcSEcCtD
Gefitinib—Conjunctivitis—Valproic Acid—migraine	0.000485	0.00268	CcSEcCtD
Gefitinib—Infection—Propranolol—migraine	0.000484	0.00268	CcSEcCtD
Gefitinib—Nervous system disorder—Propranolol—migraine	0.000478	0.00265	CcSEcCtD
Gefitinib—MAP2K5—cerebellum—migraine	0.000477	0.00734	CbGeAlD
Gefitinib—Urticaria—Amitriptyline—migraine	0.000476	0.00263	CcSEcCtD
Gefitinib—Skin disorder—Propranolol—migraine	0.000473	0.00262	CcSEcCtD
Gefitinib—Body temperature increased—Amitriptyline—migraine	0.000473	0.00262	CcSEcCtD
Gefitinib—Hepatobiliary disease—Valproic Acid—migraine	0.000471	0.00261	CcSEcCtD
Gefitinib—Epistaxis—Valproic Acid—migraine	0.00047	0.0026	CcSEcCtD
Gefitinib—Dry mouth—Verapamil—migraine	0.000457	0.00253	CcSEcCtD
Gefitinib—Pancreatitis—Gabapentin—migraine	0.000454	0.00252	CcSEcCtD
Gefitinib—Minaprine—HTR2A—migraine	0.000453	0.0475	CrCbGaD
Gefitinib—Weight decreased—Timolol—migraine	0.00045	0.00249	CcSEcCtD
Gefitinib—Haemoglobin—Valproic Acid—migraine	0.00045	0.00249	CcSEcCtD
Gefitinib—Haemorrhage—Valproic Acid—migraine	0.000447	0.00248	CcSEcCtD
Gefitinib—Infection—Verapamil—migraine	0.000445	0.00247	CcSEcCtD
Gefitinib—Urinary tract disorder—Valproic Acid—migraine	0.000442	0.00245	CcSEcCtD
Gefitinib—Shock—Verapamil—migraine	0.000441	0.00244	CcSEcCtD
Gefitinib—Oedema peripheral—Valproic Acid—migraine	0.000441	0.00244	CcSEcCtD
Gefitinib—Urethral disorder—Valproic Acid—migraine	0.000439	0.00243	CcSEcCtD
Gefitinib—Dyspnoea—Propranolol—migraine	0.000435	0.00241	CcSEcCtD
Gefitinib—STK10—brain—migraine	0.000434	0.00667	CbGeAlD
Gefitinib—Conjunctivitis—Timolol—migraine	0.000431	0.00239	CcSEcCtD
Gefitinib—Asthenia—Amitriptyline—migraine	0.00043	0.00238	CcSEcCtD
Gefitinib—ABCB1—blood vessel—migraine	0.000425	0.00653	CbGeAlD
Gefitinib—Decreased appetite—Propranolol—migraine	0.000424	0.00235	CcSEcCtD
Gefitinib—Pruritus—Amitriptyline—migraine	0.000424	0.00235	CcSEcCtD
Gefitinib—Erythema multiforme—Valproic Acid—migraine	0.000423	0.00234	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Propranolol—migraine	0.000421	0.00233	CcSEcCtD
Gefitinib—Fatigue—Propranolol—migraine	0.00042	0.00233	CcSEcCtD
Gefitinib—Dehydration—Topiramate—migraine	0.00042	0.00232	CcSEcCtD
Gefitinib—Weight decreased—Gabapentin—migraine	0.000419	0.00232	CcSEcCtD
Gefitinib—Hypotension—Verapamil—migraine	0.000419	0.00232	CcSEcCtD
Gefitinib—Epistaxis—Timolol—migraine	0.000419	0.00232	CcSEcCtD
Gefitinib—Eye disorder—Valproic Acid—migraine	0.000418	0.00232	CcSEcCtD
Gefitinib—Constipation—Propranolol—migraine	0.000417	0.00231	CcSEcCtD
Gefitinib—Pain—Propranolol—migraine	0.000417	0.00231	CcSEcCtD
Gefitinib—Pneumonia—Gabapentin—migraine	0.000416	0.0023	CcSEcCtD
Gefitinib—Infestation NOS—Gabapentin—migraine	0.000413	0.00229	CcSEcCtD
Gefitinib—Infestation—Gabapentin—migraine	0.000413	0.00229	CcSEcCtD
Gefitinib—ORM1—nervous system—migraine	0.000412	0.00633	CbGeAlD
Gefitinib—Hypokalaemia—Topiramate—migraine	0.000411	0.00227	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Gabapentin—migraine	0.00041	0.00227	CcSEcCtD
Gefitinib—Diarrhoea—Amitriptyline—migraine	0.00041	0.00227	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Topiramate—migraine	0.000406	0.00225	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Topiramate—migraine	0.000406	0.00225	CcSEcCtD
Gefitinib—Angiopathy—Valproic Acid—migraine	0.000406	0.00225	CcSEcCtD
Gefitinib—Mediastinal disorder—Valproic Acid—migraine	0.000403	0.00223	CcSEcCtD
Gefitinib—Stomatitis—Gabapentin—migraine	0.000403	0.00223	CcSEcCtD
Gefitinib—Conjunctivitis—Gabapentin—migraine	0.000402	0.00222	CcSEcCtD
Gefitinib—Arrhythmia—Valproic Acid—migraine	0.0004	0.00221	CcSEcCtD
Gefitinib—Dyspnoea—Verapamil—migraine	0.0004	0.00221	CcSEcCtD
Gefitinib—Gastrointestinal pain—Propranolol—migraine	0.000399	0.00221	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Topiramate—migraine	0.000398	0.0022	CcSEcCtD
Gefitinib—ORM1—central nervous system—migraine	0.000396	0.0061	CbGeAlD
Gefitinib—Alopecia—Valproic Acid—migraine	0.000395	0.00219	CcSEcCtD
Gefitinib—Haematuria—Gabapentin—migraine	0.000394	0.00218	CcSEcCtD
Gefitinib—Oedema peripheral—Timolol—migraine	0.000392	0.00217	CcSEcCtD
Gefitinib—Hepatobiliary disease—Gabapentin—migraine	0.000391	0.00216	CcSEcCtD
Gefitinib—Epistaxis—Gabapentin—migraine	0.00039	0.00216	CcSEcCtD
Gefitinib—Malnutrition—Valproic Acid—migraine	0.00039	0.00216	CcSEcCtD
Gefitinib—MAP2K5—brain—migraine	0.000388	0.00596	CbGeAlD
Gefitinib—Urticaria—Propranolol—migraine	0.000387	0.00214	CcSEcCtD
Gefitinib—Fatigue—Verapamil—migraine	0.000387	0.00214	CcSEcCtD
Gefitinib—Body temperature increased—Propranolol—migraine	0.000385	0.00213	CcSEcCtD
Gefitinib—Abdominal pain—Propranolol—migraine	0.000385	0.00213	CcSEcCtD
Gefitinib—Constipation—Verapamil—migraine	0.000383	0.00212	CcSEcCtD
Gefitinib—Pain—Verapamil—migraine	0.000383	0.00212	CcSEcCtD
Gefitinib—Pancreatitis—Topiramate—migraine	0.000382	0.00212	CcSEcCtD
Gefitinib—Vomiting—Amitriptyline—migraine	0.000381	0.00211	CcSEcCtD
Gefitinib—Rash—Amitriptyline—migraine	0.000377	0.00209	CcSEcCtD
Gefitinib—Dermatitis—Amitriptyline—migraine	0.000377	0.00209	CcSEcCtD
Gefitinib—Eye disorder—Timolol—migraine	0.000372	0.00206	CcSEcCtD
Gefitinib—Hepatitis—Gabapentin—migraine	0.000371	0.00205	CcSEcCtD
Gefitinib—Haemorrhage—Gabapentin—migraine	0.000371	0.00205	CcSEcCtD
Gefitinib—Cardiac disorder—Timolol—migraine	0.00037	0.00205	CcSEcCtD
Gefitinib—Urinary tract disorder—Gabapentin—migraine	0.000366	0.00203	CcSEcCtD
Gefitinib—Oedema peripheral—Gabapentin—migraine	0.000365	0.00202	CcSEcCtD
Gefitinib—Urethral disorder—Gabapentin—migraine	0.000364	0.00201	CcSEcCtD
Gefitinib—Angiopathy—Timolol—migraine	0.000361	0.002	CcSEcCtD
Gefitinib—Anaemia—Valproic Acid—migraine	0.00036	0.00199	CcSEcCtD
Gefitinib—Hypersensitivity—Propranolol—migraine	0.000359	0.00199	CcSEcCtD
Gefitinib—Mediastinal disorder—Timolol—migraine	0.000359	0.00199	CcSEcCtD
Gefitinib—Cisapride—HTR2A—migraine	0.000358	0.0375	CrCbGaD
Gefitinib—Urticaria—Verapamil—migraine	0.000356	0.00197	CcSEcCtD
Gefitinib—Angioedema—Valproic Acid—migraine	0.000356	0.00197	CcSEcCtD
Gefitinib—Arrhythmia—Timolol—migraine	0.000356	0.00197	CcSEcCtD
Gefitinib—Nausea—Amitriptyline—migraine	0.000356	0.00197	CcSEcCtD
Gefitinib—Weight decreased—Topiramate—migraine	0.000353	0.00195	CcSEcCtD
Gefitinib—Alopecia—Timolol—migraine	0.000352	0.00195	CcSEcCtD
Gefitinib—Malaise—Valproic Acid—migraine	0.000351	0.00195	CcSEcCtD
Gefitinib—CYP2C9—cardiovascular system—migraine	0.000351	0.0054	CbGeAlD
Gefitinib—Erythema multiforme—Gabapentin—migraine	0.000351	0.00194	CcSEcCtD
Gefitinib—Asthenia—Propranolol—migraine	0.00035	0.00194	CcSEcCtD
Gefitinib—Pneumonia—Topiramate—migraine	0.00035	0.00194	CcSEcCtD
Gefitinib—Infestation—Topiramate—migraine	0.000348	0.00193	CcSEcCtD
Gefitinib—Infestation NOS—Topiramate—migraine	0.000348	0.00193	CcSEcCtD
Gefitinib—Malnutrition—Timolol—migraine	0.000347	0.00192	CcSEcCtD
Gefitinib—Eye disorder—Gabapentin—migraine	0.000347	0.00192	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Topiramate—migraine	0.000345	0.00191	CcSEcCtD
Gefitinib—Cardiac disorder—Gabapentin—migraine	0.000344	0.00191	CcSEcCtD
Gefitinib—Cough—Valproic Acid—migraine	0.00034	0.00188	CcSEcCtD
Gefitinib—Stomatitis—Topiramate—migraine	0.000339	0.00188	CcSEcCtD
Gefitinib—Conjunctivitis—Topiramate—migraine	0.000338	0.00187	CcSEcCtD
Gefitinib—Mediastinal disorder—Gabapentin—migraine	0.000334	0.00185	CcSEcCtD
Gefitinib—Diarrhoea—Propranolol—migraine	0.000334	0.00185	CcSEcCtD
Gefitinib—Haematuria—Topiramate—migraine	0.000331	0.00184	CcSEcCtD
Gefitinib—Iloperidone—HTR2A—migraine	0.000331	0.0346	CrCbGaD
Gefitinib—Hypersensitivity—Verapamil—migraine	0.00033	0.00183	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000329	0.00182	CcSEcCtD
Gefitinib—Epistaxis—Topiramate—migraine	0.000328	0.00182	CcSEcCtD
Gefitinib—Alopecia—Gabapentin—migraine	0.000328	0.00182	CcSEcCtD
Gefitinib—Dry mouth—Valproic Acid—migraine	0.000324	0.0018	CcSEcCtD
Gefitinib—Malnutrition—Gabapentin—migraine	0.000323	0.00179	CcSEcCtD
Gefitinib—CYP2D6—brainstem—migraine	0.000323	0.00496	CbGeAlD
Gefitinib—Asthenia—Verapamil—migraine	0.000322	0.00178	CcSEcCtD
Gefitinib—Pruritus—Verapamil—migraine	0.000317	0.00176	CcSEcCtD
Gefitinib—Angioedema—Timolol—migraine	0.000317	0.00176	CcSEcCtD
Gefitinib—Infection—Valproic Acid—migraine	0.000316	0.00175	CcSEcCtD
Gefitinib—Haemoglobin—Topiramate—migraine	0.000314	0.00174	CcSEcCtD
Gefitinib—Haemorrhage—Topiramate—migraine	0.000312	0.00173	CcSEcCtD
Gefitinib—Hepatitis—Topiramate—migraine	0.000312	0.00173	CcSEcCtD
Gefitinib—Nervous system disorder—Valproic Acid—migraine	0.000312	0.00173	CcSEcCtD
Gefitinib—Thrombocytopenia—Valproic Acid—migraine	0.000311	0.00172	CcSEcCtD
Gefitinib—Vomiting—Propranolol—migraine	0.00031	0.00172	CcSEcCtD
Gefitinib—Skin disorder—Valproic Acid—migraine	0.000309	0.00171	CcSEcCtD
Gefitinib—Urinary tract disorder—Topiramate—migraine	0.000308	0.00171	CcSEcCtD
Gefitinib—Oedema peripheral—Topiramate—migraine	0.000307	0.0017	CcSEcCtD
Gefitinib—Rash—Propranolol—migraine	0.000307	0.0017	CcSEcCtD
Gefitinib—Dermatitis—Propranolol—migraine	0.000307	0.0017	CcSEcCtD
Gefitinib—Diarrhoea—Verapamil—migraine	0.000307	0.0017	CcSEcCtD
Gefitinib—Urethral disorder—Topiramate—migraine	0.000306	0.00169	CcSEcCtD
Gefitinib—Anorexia—Valproic Acid—migraine	0.000303	0.00168	CcSEcCtD
Gefitinib—Cough—Timolol—migraine	0.000303	0.00168	CcSEcCtD
Gefitinib—Anaemia—Gabapentin—migraine	0.000298	0.00165	CcSEcCtD
Gefitinib—Hypotension—Valproic Acid—migraine	0.000297	0.00165	CcSEcCtD
Gefitinib—Erythema multiforme—Topiramate—migraine	0.000295	0.00163	CcSEcCtD
Gefitinib—Angioedema—Gabapentin—migraine	0.000295	0.00163	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000293	0.00162	CcSEcCtD
Gefitinib—Eye disorder—Topiramate—migraine	0.000292	0.00162	CcSEcCtD
Gefitinib—Malaise—Gabapentin—migraine	0.000291	0.00161	CcSEcCtD
Gefitinib—Cardiac disorder—Topiramate—migraine	0.00029	0.0016	CcSEcCtD
Gefitinib—Nausea—Propranolol—migraine	0.00029	0.0016	CcSEcCtD
Gefitinib—Dry mouth—Timolol—migraine	0.000289	0.0016	CcSEcCtD
Gefitinib—Vomiting—Verapamil—migraine	0.000285	0.00158	CcSEcCtD
Gefitinib—Dyspnoea—Valproic Acid—migraine	0.000283	0.00157	CcSEcCtD
Gefitinib—Angiopathy—Topiramate—migraine	0.000283	0.00157	CcSEcCtD
Gefitinib—Rash—Verapamil—migraine	0.000283	0.00157	CcSEcCtD
Gefitinib—Dermatitis—Verapamil—migraine	0.000282	0.00156	CcSEcCtD
Gefitinib—Cough—Gabapentin—migraine	0.000282	0.00156	CcSEcCtD
Gefitinib—Mediastinal disorder—Topiramate—migraine	0.000281	0.00156	CcSEcCtD
Gefitinib—Infection—Timolol—migraine	0.000281	0.00156	CcSEcCtD
Gefitinib—Shock—Timolol—migraine	0.000278	0.00154	CcSEcCtD
Gefitinib—Nervous system disorder—Timolol—migraine	0.000278	0.00154	CcSEcCtD
Gefitinib—Decreased appetite—Valproic Acid—migraine	0.000276	0.00153	CcSEcCtD
Gefitinib—ALB—brain—migraine	0.000276	0.00424	CbGeAlD
Gefitinib—Alopecia—Topiramate—migraine	0.000276	0.00153	CcSEcCtD
Gefitinib—Skin disorder—Timolol—migraine	0.000275	0.00152	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Valproic Acid—migraine	0.000274	0.00152	CcSEcCtD
Gefitinib—Fatigue—Valproic Acid—migraine	0.000274	0.00152	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000273	0.00151	CcSEcCtD
Gefitinib—Constipation—Valproic Acid—migraine	0.000272	0.00151	CcSEcCtD
Gefitinib—Pain—Valproic Acid—migraine	0.000272	0.00151	CcSEcCtD
Gefitinib—Malnutrition—Topiramate—migraine	0.000272	0.0015	CcSEcCtD
Gefitinib—Anorexia—Timolol—migraine	0.00027	0.00149	CcSEcCtD
Gefitinib—Dry mouth—Gabapentin—migraine	0.000269	0.00149	CcSEcCtD
Gefitinib—Nausea—Verapamil—migraine	0.000266	0.00148	CcSEcCtD
Gefitinib—Hypotension—Timolol—migraine	0.000264	0.00146	CcSEcCtD
Gefitinib—ABCB1—trigeminal ganglion—migraine	0.000262	0.00403	CbGeAlD
Gefitinib—Infection—Gabapentin—migraine	0.000262	0.00145	CcSEcCtD
Gefitinib—Gastrointestinal pain—Valproic Acid—migraine	0.00026	0.00144	CcSEcCtD
Gefitinib—Shock—Gabapentin—migraine	0.000259	0.00144	CcSEcCtD
Gefitinib—Nervous system disorder—Gabapentin—migraine	0.000258	0.00143	CcSEcCtD
Gefitinib—Thrombocytopenia—Gabapentin—migraine	0.000258	0.00143	CcSEcCtD
Gefitinib—Skin disorder—Gabapentin—migraine	0.000256	0.00142	CcSEcCtD
Gefitinib—Urticaria—Valproic Acid—migraine	0.000253	0.0014	CcSEcCtD
Gefitinib—Dyspnoea—Timolol—migraine	0.000252	0.0014	CcSEcCtD
Gefitinib—Abdominal pain—Valproic Acid—migraine	0.000251	0.00139	CcSEcCtD
Gefitinib—Body temperature increased—Valproic Acid—migraine	0.000251	0.00139	CcSEcCtD
Gefitinib—Anorexia—Gabapentin—migraine	0.000251	0.00139	CcSEcCtD
Gefitinib—Anaemia—Topiramate—migraine	0.000251	0.00139	CcSEcCtD
Gefitinib—CYP1A1—head—migraine	0.000247	0.0038	CbGeAlD
Gefitinib—Hypotension—Gabapentin—migraine	0.000246	0.00136	CcSEcCtD
Gefitinib—Decreased appetite—Timolol—migraine	0.000246	0.00136	CcSEcCtD
Gefitinib—Malaise—Topiramate—migraine	0.000245	0.00136	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Timolol—migraine	0.000244	0.00135	CcSEcCtD
Gefitinib—Fatigue—Timolol—migraine	0.000244	0.00135	CcSEcCtD
Gefitinib—Pain—Timolol—migraine	0.000242	0.00134	CcSEcCtD
Gefitinib—Cough—Topiramate—migraine	0.000237	0.00131	CcSEcCtD
Gefitinib—Dyspnoea—Gabapentin—migraine	0.000235	0.0013	CcSEcCtD
Gefitinib—Hypersensitivity—Valproic Acid—migraine	0.000234	0.0013	CcSEcCtD
Gefitinib—CYP1A1—nervous system—migraine	0.000234	0.0036	CbGeAlD
Gefitinib—ABCG2—cerebellum—migraine	0.000232	0.00357	CbGeAlD
Gefitinib—Gastrointestinal pain—Timolol—migraine	0.000231	0.00128	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.00023	0.00127	CcSEcCtD
Gefitinib—Decreased appetite—Gabapentin—migraine	0.000229	0.00127	CcSEcCtD
Gefitinib—Asthenia—Valproic Acid—migraine	0.000228	0.00126	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Gabapentin—migraine	0.000228	0.00126	CcSEcCtD
Gefitinib—Fatigue—Gabapentin—migraine	0.000227	0.00126	CcSEcCtD
Gefitinib—Dry mouth—Topiramate—migraine	0.000226	0.00125	CcSEcCtD
Gefitinib—CYP1A1—central nervous system—migraine	0.000225	0.00347	CbGeAlD
Gefitinib—Constipation—Gabapentin—migraine	0.000225	0.00125	CcSEcCtD
Gefitinib—Pain—Gabapentin—migraine	0.000225	0.00125	CcSEcCtD
Gefitinib—Pruritus—Valproic Acid—migraine	0.000225	0.00125	CcSEcCtD
Gefitinib—Urticaria—Timolol—migraine	0.000225	0.00125	CcSEcCtD
Gefitinib—Abdominal pain—Timolol—migraine	0.000224	0.00124	CcSEcCtD
Gefitinib—Body temperature increased—Timolol—migraine	0.000224	0.00124	CcSEcCtD
Gefitinib—Infection—Topiramate—migraine	0.00022	0.00122	CcSEcCtD
Gefitinib—Shock—Topiramate—migraine	0.000218	0.00121	CcSEcCtD
Gefitinib—Diarrhoea—Valproic Acid—migraine	0.000218	0.0012	CcSEcCtD
Gefitinib—Nervous system disorder—Topiramate—migraine	0.000217	0.0012	CcSEcCtD
Gefitinib—Thrombocytopenia—Topiramate—migraine	0.000217	0.0012	CcSEcCtD
Gefitinib—Gastrointestinal pain—Gabapentin—migraine	0.000216	0.00119	CcSEcCtD
Gefitinib—Skin disorder—Topiramate—migraine	0.000215	0.00119	CcSEcCtD
Gefitinib—Anorexia—Topiramate—migraine	0.000211	0.00117	CcSEcCtD
Gefitinib—Urticaria—Gabapentin—migraine	0.000209	0.00116	CcSEcCtD
Gefitinib—Hypersensitivity—Timolol—migraine	0.000209	0.00116	CcSEcCtD
Gefitinib—Abdominal pain—Gabapentin—migraine	0.000208	0.00115	CcSEcCtD
Gefitinib—Body temperature increased—Gabapentin—migraine	0.000208	0.00115	CcSEcCtD
Gefitinib—Hypotension—Topiramate—migraine	0.000207	0.00115	CcSEcCtD
Gefitinib—Asthenia—Timolol—migraine	0.000203	0.00112	CcSEcCtD
Gefitinib—Vomiting—Valproic Acid—migraine	0.000202	0.00112	CcSEcCtD
Gefitinib—Rash—Valproic Acid—migraine	0.0002	0.00111	CcSEcCtD
Gefitinib—Dermatitis—Valproic Acid—migraine	0.0002	0.00111	CcSEcCtD
Gefitinib—Pruritus—Timolol—migraine	0.0002	0.00111	CcSEcCtD
Gefitinib—Dyspnoea—Topiramate—migraine	0.000198	0.0011	CcSEcCtD
Gefitinib—Hypersensitivity—Gabapentin—migraine	0.000194	0.00108	CcSEcCtD
Gefitinib—Diarrhoea—Timolol—migraine	0.000194	0.00107	CcSEcCtD
Gefitinib—Decreased appetite—Topiramate—migraine	0.000193	0.00107	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Topiramate—migraine	0.000191	0.00106	CcSEcCtD
Gefitinib—Fatigue—Topiramate—migraine	0.000191	0.00106	CcSEcCtD
Gefitinib—Constipation—Topiramate—migraine	0.00019	0.00105	CcSEcCtD
Gefitinib—Pain—Topiramate—migraine	0.00019	0.00105	CcSEcCtD
Gefitinib—ABCB1—cardiovascular system—migraine	0.000189	0.00291	CbGeAlD
Gefitinib—Asthenia—Gabapentin—migraine	0.000189	0.00105	CcSEcCtD
Gefitinib—Nausea—Valproic Acid—migraine	0.000189	0.00105	CcSEcCtD
Gefitinib—ABCG2—brain—migraine	0.000189	0.0029	CbGeAlD
Gefitinib—Pruritus—Gabapentin—migraine	0.000186	0.00103	CcSEcCtD
Gefitinib—Gastrointestinal pain—Topiramate—migraine	0.000181	0.001	CcSEcCtD
Gefitinib—Diarrhoea—Gabapentin—migraine	0.00018	0.000999	CcSEcCtD
Gefitinib—Vomiting—Timolol—migraine	0.00018	0.000997	CcSEcCtD
Gefitinib—CYP1A1—brain—migraine	0.000179	0.00275	CbGeAlD
Gefitinib—Rash—Timolol—migraine	0.000178	0.000988	CcSEcCtD
Gefitinib—CYP2D6—head—migraine	0.000178	0.00274	CbGeAlD
Gefitinib—Dermatitis—Timolol—migraine	0.000178	0.000988	CcSEcCtD
Gefitinib—Urticaria—Topiramate—migraine	0.000176	0.000976	CcSEcCtD
Gefitinib—Abdominal pain—Topiramate—migraine	0.000175	0.000971	CcSEcCtD
Gefitinib—Body temperature increased—Topiramate—migraine	0.000175	0.000971	CcSEcCtD
Gefitinib—CYP3A4—nervous system—migraine	0.000172	0.00264	CbGeAlD
Gefitinib—CYP2D6—nervous system—migraine	0.000169	0.0026	CbGeAlD
Gefitinib—Nausea—Timolol—migraine	0.000168	0.000931	CcSEcCtD
Gefitinib—Vomiting—Gabapentin—migraine	0.000168	0.000928	CcSEcCtD
Gefitinib—Rash—Gabapentin—migraine	0.000166	0.00092	CcSEcCtD
Gefitinib—Dermatitis—Gabapentin—migraine	0.000166	0.00092	CcSEcCtD
Gefitinib—CYP3A4—central nervous system—migraine	0.000165	0.00254	CbGeAlD
Gefitinib—Hypersensitivity—Topiramate—migraine	0.000163	0.000905	CcSEcCtD
Gefitinib—CYP2D6—central nervous system—migraine	0.000163	0.0025	CbGeAlD
Gefitinib—CYP2D6—cerebellum—migraine	0.000159	0.00245	CbGeAlD
Gefitinib—Asthenia—Topiramate—migraine	0.000159	0.000881	CcSEcCtD
Gefitinib—Pruritus—Topiramate—migraine	0.000157	0.000869	CcSEcCtD
Gefitinib—Nausea—Gabapentin—migraine	0.000157	0.000867	CcSEcCtD
Gefitinib—Diarrhoea—Topiramate—migraine	0.000152	0.00084	CcSEcCtD
Gefitinib—IRAK1—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000143	0.00369	CbGpPWpGaD
Gefitinib—Vomiting—Topiramate—migraine	0.000141	0.000781	CcSEcCtD
Gefitinib—IRAK1—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000141	0.00363	CbGpPWpGaD
Gefitinib—Rash—Topiramate—migraine	0.00014	0.000774	CcSEcCtD
Gefitinib—Dermatitis—Topiramate—migraine	0.00014	0.000774	CcSEcCtD
Gefitinib—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	0.000136	0.00351	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Telomerase—ESR1—migraine	0.000135	0.00349	CbGpPWpGaD
Gefitinib—IRAK1—MyD88-independent cascade—FOS—migraine	0.000135	0.00348	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—PGR—migraine	0.000133	0.00343	CbGpPWpGaD
Gefitinib—IRAK1—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000132	0.0034	CbGpPWpGaD
Gefitinib—Nausea—Topiramate—migraine	0.000132	0.00073	CcSEcCtD
Gefitinib—EGFR—Developmental Biology—SCN1A—migraine	0.00013	0.00336	CbGpPWpGaD
Gefitinib—CYP2D6—brain—migraine	0.000129	0.00199	CbGeAlD
Gefitinib—ABCB1—head—migraine	0.000128	0.00197	CbGeAlD
Gefitinib—EGFR—LPA receptor mediated events—FOS—migraine	0.000128	0.0033	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB4—ESR1—migraine	0.000128	0.00329	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—RAMP1—migraine	0.000125	0.00323	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CALCRL—migraine	0.000125	0.00323	CbGpPWpGaD
Gefitinib—MAP2K5—BDNF signaling pathway—FOS—migraine	0.000125	0.00321	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Telomerase—FOS—migraine	0.000122	0.00314	CbGpPWpGaD
Gefitinib—ABCB1—nervous system—migraine	0.000122	0.00187	CbGeAlD
Gefitinib—IRAK1—Activated TLR4 signalling—FOS—migraine	0.000121	0.00313	CbGpPWpGaD
Gefitinib—ABCB1—central nervous system—migraine	0.000117	0.0018	CbGeAlD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000117	0.00301	CbGpPWpGaD
Gefitinib—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	0.000117	0.003	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—BDNF—migraine	0.000116	0.00299	CbGpPWpGaD
Gefitinib—MAP2K5—Insulin Signaling—FOS—migraine	0.000115	0.00295	CbGpPWpGaD
Gefitinib—ABCB1—cerebellum—migraine	0.000114	0.00176	CbGeAlD
Gefitinib—IRAK1—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.000114	0.00294	CbGpPWpGaD
Gefitinib—MAP2K5—EGF/EGFR Signaling Pathway—FOS—migraine	0.000113	0.00292	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—SCN2A—migraine	0.000111	0.00285	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.00011	0.00284	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—FOS—migraine	0.00011	0.00284	CbGpPWpGaD
Gefitinib—IRAK4—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000107	0.00275	CbGpPWpGaD
Gefitinib—MKNK1—Disease—LRP1—migraine	0.000106	0.00274	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000103	0.00266	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000103	0.00266	CbGpPWpGaD
Gefitinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000103	0.00266	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000103	0.00265	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000102	0.00263	CbGpPWpGaD
Gefitinib—IRAK1—Toll-Like Receptors Cascades—FOS—migraine	0.000102	0.00262	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MEF2D—migraine	0.000101	0.00261	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000101	0.0026	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000101	0.0026	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TGFBR2—migraine	9.9e-05	0.00255	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	9.89e-05	0.00255	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CALCRL—migraine	9.74e-05	0.00251	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RAMP1—migraine	9.74e-05	0.00251	CbGpPWpGaD
Gefitinib—MKNK1—MAPK Signaling Pathway—TNF—migraine	9.63e-05	0.00248	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	9.62e-05	0.00248	CbGpPWpGaD
Gefitinib—ABCB1—brain—migraine	9.3e-05	0.00143	CbGeAlD
Gefitinib—MKNK1—Signaling Pathways—HTR1D—migraine	9.1e-05	0.00235	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TGFBR2—migraine	9.09e-05	0.00234	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—MTHFR—migraine	8.98e-05	0.00231	CbGpPWpGaD
Gefitinib—EGFR—Aryl Hydrocarbon Receptor—TNF—migraine	8.96e-05	0.00231	CbGpPWpGaD
Gefitinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	8.96e-05	0.00231	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	8.78e-05	0.00226	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—BDNF—migraine	8.75e-05	0.00226	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—FOS—migraine	8.61e-05	0.00222	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR2B—migraine	8.46e-05	0.00218	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—TRPM8—migraine	8.4e-05	0.00217	CbGpPWpGaD
Gefitinib—IRAK4—Regulation of toll-like receptor signaling pathway—TNF—migraine	8.33e-05	0.00215	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—LRP1—migraine	8.27e-05	0.00213	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	7.89e-05	0.00204	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—TNF—migraine	7.89e-05	0.00203	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—FOS—migraine	7.84e-05	0.00202	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CALCRL—migraine	7.7e-05	0.00198	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RAMP1—migraine	7.7e-05	0.00198	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—LRP1—migraine	7.45e-05	0.00192	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RAMP1—migraine	7.42e-05	0.00191	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CALCRL—migraine	7.42e-05	0.00191	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	7.36e-05	0.0019	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—ESR1—migraine	7.14e-05	0.00184	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—MTHFR—migraine	7.13e-05	0.00184	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—ESR1—migraine	7.11e-05	0.00183	CbGpPWpGaD
Gefitinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—migraine	7.08e-05	0.00183	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR1D—migraine	7.08e-05	0.00182	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CALCRL—migraine	6.99e-05	0.0018	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—RAMP1—migraine	6.99e-05	0.0018	CbGpPWpGaD
Gefitinib—MKNK1—Disease—CALCA—migraine	6.85e-05	0.00177	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2B—migraine	6.58e-05	0.0017	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	6.37e-05	0.00164	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	6.37e-05	0.00164	CbGpPWpGaD
Gefitinib—ERBB3—Disease—LRP1—migraine	6.3e-05	0.00162	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	6.3e-05	0.00162	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CALCRL—migraine	6.18e-05	0.00159	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RAMP1—migraine	6.18e-05	0.00159	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—FOS—migraine	6.09e-05	0.00157	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	6.07e-05	0.00156	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—TNF—migraine	5.92e-05	0.00153	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	5.92e-05	0.00153	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—FOS—migraine	5.91e-05	0.00152	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—LRP1—migraine	5.79e-05	0.00149	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NOTCH4—migraine	5.71e-05	0.00147	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	5.67e-05	0.00146	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	5.66e-05	0.00146	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—TNF—migraine	5.66e-05	0.00146	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR1D—migraine	5.59e-05	0.00144	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	5.58e-05	0.00144	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	5.58e-05	0.00144	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—migraine	5.53e-05	0.00143	CbGpPWpGaD
Gefitinib—MKNK1—Disease—TGFBR2—migraine	5.52e-05	0.00142	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR1B—migraine	5.51e-05	0.00142	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—HTR3A—migraine	5.42e-05	0.0014	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR1D—migraine	5.39e-05	0.00139	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CALCA—migraine	5.33e-05	0.00137	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR1A—migraine	5.31e-05	0.00137	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—PGR—migraine	5.23e-05	0.00135	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NPS—migraine	5.23e-05	0.00135	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TAC1—migraine	5.23e-05	0.00135	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2B—migraine	5.2e-05	0.00134	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR2C—migraine	5.12e-05	0.00132	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR1D—migraine	5.08e-05	0.00131	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2B—migraine	5.01e-05	0.00129	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—EDNRA—migraine	4.98e-05	0.00129	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—FOS—migraine	4.96e-05	0.00128	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NOTCH3—migraine	4.86e-05	0.00125	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CALCA—migraine	4.8e-05	0.00124	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—TNF—migraine	4.75e-05	0.00123	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	4.74e-05	0.00122	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2B—migraine	4.72e-05	0.00122	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—LRP1—migraine	4.58e-05	0.00118	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR1D—migraine	4.49e-05	0.00116	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR7—migraine	4.49e-05	0.00116	CbGpPWpGaD
Gefitinib—MKNK1—Disease—MTHFR—migraine	4.48e-05	0.00116	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NOTCH4—migraine	4.44e-05	0.00115	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—LRP1—migraine	4.41e-05	0.00114	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFBR2—migraine	4.29e-05	0.00111	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR1B—migraine	4.29e-05	0.00111	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TNF—migraine	4.22e-05	0.00109	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2B—migraine	4.17e-05	0.00108	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RAMP1—migraine	4.13e-05	0.00107	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CALCRL—migraine	4.13e-05	0.00107	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR1A—migraine	4.13e-05	0.00106	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TAC1—migraine	4.06e-05	0.00105	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NPS—migraine	4.06e-05	0.00105	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—PGR—migraine	4.06e-05	0.00105	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CALCA—migraine	4.06e-05	0.00105	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2C—migraine	3.99e-05	0.00103	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	3.98e-05	0.00103	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—FOS—migraine	3.96e-05	0.00102	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—EDNRA—migraine	3.88e-05	0.001	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TNF—migraine	3.87e-05	0.000997	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFBR2—migraine	3.87e-05	0.000997	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NOTCH3—migraine	3.78e-05	0.000974	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—TNF—migraine	3.75e-05	0.000966	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CALCA—migraine	3.73e-05	0.000962	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LRP1—migraine	3.67e-05	0.000947	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NOTCH4—migraine	3.51e-05	0.000906	CbGpPWpGaD
Gefitinib—EGFR—Disease—LRP1—migraine	3.51e-05	0.000904	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CACNA1A—migraine	3.5e-05	0.000901	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR7—migraine	3.49e-05	0.0009	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—MTHFR—migraine	3.49e-05	0.000899	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR1B—migraine	3.39e-05	0.000874	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NOTCH4—migraine	3.39e-05	0.000873	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—FOS—migraine	3.29e-05	0.000849	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFBR2—migraine	3.27e-05	0.000843	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR1B—migraine	3.27e-05	0.000842	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR1A—migraine	3.26e-05	0.000841	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PGR—migraine	3.21e-05	0.000828	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TAC1—migraine	3.21e-05	0.000828	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NPS—migraine	3.21e-05	0.000828	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TNF—migraine	3.18e-05	0.000819	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2C—migraine	3.15e-05	0.000812	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR1A—migraine	3.14e-05	0.000811	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR2A—migraine	3.14e-05	0.000811	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PGR—migraine	3.1e-05	0.000798	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NPS—migraine	3.1e-05	0.000798	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TAC1—migraine	3.1e-05	0.000798	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR1B—migraine	3.08e-05	0.000794	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—TNF—migraine	3.07e-05	0.000792	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—EDNRA—migraine	3.06e-05	0.00079	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2C—migraine	3.04e-05	0.000783	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFBR2—migraine	3.01e-05	0.000775	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR1D—migraine	3e-05	0.000774	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.99e-05	0.00077	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NOTCH3—migraine	2.99e-05	0.00077	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR1A—migraine	2.96e-05	0.000764	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—EDNRA—migraine	2.95e-05	0.000762	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CALCA—migraine	2.95e-05	0.000761	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—TNF—migraine	2.93e-05	0.000756	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—NPS—migraine	2.92e-05	0.000752	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TAC1—migraine	2.92e-05	0.000752	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—FOS—migraine	2.89e-05	0.000745	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NOTCH3—migraine	2.88e-05	0.000742	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.87e-05	0.000739	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2C—migraine	2.86e-05	0.000738	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CALCA—migraine	2.84e-05	0.000733	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NOTCH4—migraine	2.82e-05	0.000727	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2B—migraine	2.79e-05	0.000719	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—ESR1—migraine	2.79e-05	0.000719	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—EDNRA—migraine	2.78e-05	0.000718	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR7—migraine	2.76e-05	0.000711	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR1B—migraine	2.72e-05	0.000701	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CALCA—migraine	2.68e-05	0.000691	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR7—migraine	2.66e-05	0.000686	CbGpPWpGaD
Gefitinib—ERBB3—Disease—MTHFR—migraine	2.66e-05	0.000685	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR1A—migraine	2.62e-05	0.000675	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PGR—migraine	2.58e-05	0.000665	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NPS—migraine	2.58e-05	0.000665	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TAC1—migraine	2.58e-05	0.000665	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2C—migraine	2.53e-05	0.000652	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR7—migraine	2.51e-05	0.000646	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CACNA1A—migraine	2.5e-05	0.000646	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EDNRA—migraine	2.46e-05	0.000634	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LRP1—migraine	2.46e-05	0.000633	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2A—migraine	2.44e-05	0.00063	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NOTCH3—migraine	2.4e-05	0.000618	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFBR2—migraine	2.38e-05	0.000613	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CALCA—migraine	2.37e-05	0.00061	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CACNA1A—migraine	2.37e-05	0.00061	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—FOS—migraine	2.3e-05	0.000594	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFBR2—migraine	2.29e-05	0.000591	CbGpPWpGaD
Gefitinib—EGFR—Disease—CALCA—migraine	2.26e-05	0.000583	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR7—migraine	2.21e-05	0.000571	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—FOS—migraine	2.2e-05	0.000568	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—ESR1—migraine	2.17e-05	0.000559	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CACNA1A—migraine	2.16e-05	0.000556	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNA1A—migraine	1.94e-05	0.000499	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2A—migraine	1.93e-05	0.000498	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—FOS—migraine	1.92e-05	0.000495	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFBR2—migraine	1.91e-05	0.000492	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNA1A—migraine	1.89e-05	0.000487	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOTCH4—migraine	1.88e-05	0.000486	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2A—migraine	1.86e-05	0.00048	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFBR2—migraine	1.82e-05	0.000469	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR1B—migraine	1.82e-05	0.000469	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNA1A—migraine	1.78e-05	0.000459	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNA1A—migraine	1.77e-05	0.000455	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2A—migraine	1.76e-05	0.000453	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR1A—migraine	1.75e-05	0.000451	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TAC1—migraine	1.72e-05	0.000444	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NPS—migraine	1.72e-05	0.000444	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PGR—migraine	1.72e-05	0.000444	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ESR1—migraine	1.72e-05	0.000442	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2C—migraine	1.69e-05	0.000436	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ESR1—migraine	1.65e-05	0.000426	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—EDNRA—migraine	1.64e-05	0.000424	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOTCH3—migraine	1.6e-05	0.000413	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CALCA—migraine	1.58e-05	0.000408	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2A—migraine	1.55e-05	0.0004	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR7—migraine	1.48e-05	0.000382	CbGpPWpGaD
Gefitinib—EGFR—Disease—MTHFR—migraine	1.48e-05	0.000381	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.45e-05	0.000373	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ESR1—migraine	1.38e-05	0.000355	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—migraine	1.34e-05	0.000346	CbGpPWpGaD
Gefitinib—EGFR—Immune System—FOS—migraine	1.28e-05	0.000331	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFBR2—migraine	1.28e-05	0.000329	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNA1A—migraine	1.16e-05	0.0003	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MTHFR—migraine	1.16e-05	0.000298	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—migraine	1.04e-05	0.000267	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ESR1—migraine	9.2e-06	0.000237	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MTHFR—migraine	8.28e-06	0.000214	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MTHFR—migraine	7.83e-06	0.000202	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MTHFR—migraine	7.13e-06	0.000184	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MTHFR—migraine	6.4e-06	0.000165	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MTHFR—migraine	6.25e-06	0.000161	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MTHFR—migraine	5.89e-06	0.000152	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MTHFR—migraine	5.84e-06	0.000151	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MTHFR—migraine	3.85e-06	9.93e-05	CbGpPWpGaD
